These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27046792)

  • 21. A study of potential toxic effects after repeated 10-week administration of a new iron chelator--salicylaldehyde isonicotinoyl hydrazone (SIH) to rabbits.
    Klimtová I; Simůnek T; Mazurová Y; Kaplanová J; Sterba M; Hrdina R; Gersl V; Adamcová M; Ponka P
    Acta Medica (Hradec Kralove); 2003; 46(4):163-70. PubMed ID: 14965167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
    Kurz T; Gustafsson B; Brunk UT
    FEBS J; 2006 Jul; 273(13):3106-17. PubMed ID: 16762036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
    Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
    Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
    Chen YL; Kong X; Xie Y; Hider RC
    J Inorg Biochem; 2018 Mar; 180():194-203. PubMed ID: 29329026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative Activities.
    Hrušková K; Potůčková E; Opálka L; Hergeselová T; Hašková P; Kovaříková P; Šimůnek T; Vávrová K
    Chem Res Toxicol; 2018 Jun; 31(6):435-446. PubMed ID: 29766723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designing salicylaldehyde isonicotinoyl hydrazones as Cu(II) ionophores with tunable chelation and release of copper for hitting redox Achilles heel of cancer cells.
    Ji Y; Dai F; Zhou B
    Free Radic Biol Med; 2018 Dec; 129():215-226. PubMed ID: 30240704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variable inhibitory effects on the formation of dinitrosyl iron complexes by deferoxamine and salicylaldehyde isonicotinoyl hydrazone in K562 cells.
    Meczynska S; Lewandowska H; Sochanowicz B; Sadlo J; Kruszewski M
    Hemoglobin; 2008; 32(1-2):157-63. PubMed ID: 18274993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chelation of lysosomal iron protects against ionizing radiation.
    Berndt C; Kurz T; Selenius M; Fernandes AP; Edgren MR; Brunk UT
    Biochem J; 2010 Dec; 432(2):295-301. PubMed ID: 20846118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications.
    Hrušková K; Potůčková E; Hergeselová T; Liptáková L; Hašková P; Mingas P; Kovaříková P; Šimůnek T; Vávrová K
    Eur J Med Chem; 2016 Sep; 120():97-110. PubMed ID: 27187862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac troponins following repeated administration of an iron chelator--salicylaldehyde isonicotinoyl hydrazone (SIH)--in rabbits.
    Adamcová M; Sterba M; Klimtová I; Simůnek T; Hrdina R; Gersl V; Ponka P
    Acta Medica (Hradec Kralove); 2003; 46(4):171-4. PubMed ID: 14965168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modifications of boronic ester pro-chelators triggered by hydrogen peroxide tune reactivity to inhibit metal-promoted oxidative stress.
    Charkoudian LK; Pham DM; Kwon AM; Vangeloff AD; Franz KJ
    Dalton Trans; 2007 Nov; (43):5031-42. PubMed ID: 17992288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture.
    Baker E; Richardson D; Gross S; Ponka P
    Hepatology; 1992 Mar; 15(3):492-501. PubMed ID: 1544632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.
    Bendova P; Mackova E; Haskova P; Vavrova A; Jirkovsky E; Sterba M; Popelova O; Kalinowski DS; Kovarikova P; Vavrova K; Richardson DR; Simunek T
    Chem Res Toxicol; 2010 Jun; 23(6):1105-14. PubMed ID: 20521781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel iron chelator that does not induce HIF-1 activity.
    Creighton-Gutteridge M; Tyrrell RM
    Free Radic Biol Med; 2002 Aug; 33(3):356-63. PubMed ID: 12126757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the stability of aromatic hydrazones in plasma and related biological material.
    Kovaríková P; Mrkvicková Z; Klimes J
    J Pharm Biomed Anal; 2008 Jun; 47(2):360-70. PubMed ID: 18294799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
    Lim CK; Kalinowski DS; Richardson DR
    Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multifunctional, light-activated prochelator inhibits UVA-induced oxidative stress.
    Franks AT; Wang Q; Franz KJ
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4843-4847. PubMed ID: 26152427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of mitochondrial ferritin sensitizes cells to oxidative stress via an iron-mediated mechanism.
    Lu Z; Nie G; Li Y; Soe-Lin S; Tao Y; Cao Y; Zhang Z; Liu N; Ponka P; Zhao B
    Antioxid Redox Signal; 2009 Aug; 11(8):1791-803. PubMed ID: 19271990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.
    Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI
    J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferric-salicylaldehyde isonicotinoyl hydrazone, a synthetic iron chelate, alleviates defective iron utilization by reticulocytes of the Belgrade rat.
    Garrick LM; Gniecko K; Hoke JE; al-Nakeeb A; Ponka P; Garrick MD
    J Cell Physiol; 1991 Mar; 146(3):460-5. PubMed ID: 2022700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.